2m 2m 2m 2m 2m 2m 2m
ASSEMBLY BIO (ASMB)
NASDAQ
$24.54-$0.04 (-0.14%)
Price as of Jun 03, 2026 4:15 PM EDT- $548.1MMarket Cap
- 61.12%1-Year Change
- BiotechnologyIndustry
ASSEMBLY BIO (ASMB)
$24.54-$0.04 (-0.14%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 72.3M +153.52% | 28.5M +298.16% | 7.2M +14.53% | 6.3M 0.00% | |
Cost of Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Gross Profit | 72.3M +153.52% | 28.5M +298.16% | 7.2M +14.53% | 6.3M 0.00% | |
Sales and Marketing Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | -64.8M +15.88% | -55.9M +14.38% | -48.9M -30.12% | -70.0M +2.12% | |
Depreciation and Amortization Expense | 129,000 0.00% | 129,000 -71.33% | 450,000 -9.64% | 498,000 +6.87% | |
Total Operating Expenses | 84.4M +14.18% | 73.9M +2.97% | 71.8M -23.70% | 94.1M -32.26% | |
Operating Profit | -12.1M -73.32% | -45.4M -29.74% | -64.6M -31.31% | -94.1M -29.07% | |
Interest Income | 6.0M +7.59% | 5.6M +61.49% | 3.5M +237.67% | 1.0M +238.41% | |
Interest Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Income and Expense and Net | 6.0M +7.59% | 5.6M +61.49% | 3.5M +237.67% | 1.0M +238.41% | |
Total Nonoperating Income and Expense | 6.0M +7.59% | 5.6M +61.49% | 3.5M +237.67% | 1.0M +238.41% | |
Income before Taxes | -6.1M -84.64% | -39.8M -34.89% | -61.2M -34.26% | -93.1M -29.68% | |
Income Taxes | 0 -100.00% | 330,000 +900.00% | 33,000 N/A | 0 +100.00% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -6.1M -84.76% | -40.2M -34.38% | -61.2M -34.23% | -93.1M -28.31% | |
Net Income from Continuing Operations Applicable to Common | -6.1M -84.64% | -39.8M -34.89% | -61.2M -34.26% | -93.1M -29.68% | |
Basic EPS and Net Income | -0.55 -91.78% | -6.69 -50.00% | -13.38 +596.88% | -1.92 -36.00% | |
Diluted EPS and Net Income | -0.55 -91.78% | -6.69 -50.00% | -13.38 +596.88% | -1.92 -36.00% | |
Basic Weighted Average Shares | 11.2M +86.71% | 6.0M +31.18% | 4.6M -90.54% | 48.4M +11.85% | |
Diluted Weighted Average Shares | 11.2M +86.71% | 6.0M +31.18% | 4.6M -90.54% | 48.4M +11.85% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 58.5M +52.44% | 38.3M +93.26% | 19.8M -62.15% | 52.4M +14.88% | |
Short-Term Investments | 189.7M +157.21% | 73.7M -33.21% | 110.4M +181.71% | 39.2M -61.20% | |
Cash and Cash Equivalents and Short-Term Investments | 248.1M +121.37% | 112.1M -13.95% | 130.2M +42.18% | 91.6M -37.52% | |
Total Current Assets | 254.5M +120.38% | 115.5M -13.67% | 133.8M +37.97% | 97.0M -37.12% | |
Accumulated Depreciation | N/A N/A | N/A N/A | 210,000 -87.55% | 1.7M +39.77% | |
Property and Plant and Equipment and Net | 221,000 -22.18% | 284,000 -26.23% | 385,000 -48.18% | 743,000 -34.77% | |
Total Long-Term Assets | 312,000 0.00% | 312,000 0.00% | 312,000 -64.90% | 889,000 -47.80% | |
Total Assets | 257.6M +116.16% | 119.2M -12.90% | 136.8M +34.41% | 101.8M -46.72% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 48.8M +2.04% | 47.8M +21.87% | 39.2M +140.70% | 16.3M +1.39% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 2.1M -94.58% | 38.0M -32.73% | 56.5M +1,893.68% | 2.8M -74.51% | |
Total Liabilities | 50.8M -40.75% | 85.8M -10.36% | 95.7M +400.40% | 19.1M -13.56% | |
Retained Earnings | -832.0M +0.74% | -825.9M +5.11% | -785.7M +8.45% | -724.5M +14.74% | |
Total Stockholders Equity | 206.8M +519.78% | 33.4M -18.83% | 41.1M -50.28% | 82.7M -51.07% | |
Total Shares Outstanding | 15.9M +112.62% | 7.5M +36.01% | 5.5M -88.79% | 48.9M +1.61% | |
Cash Flow | |||||
Cash from Operating Activities | -41.1M -19.61% | -51.1M -324.76% | 22.7M +126.93% | -84.5M -9.56% | |
Capital Expenditures | 66,000 +135.71% | 28,000 -89.02% | 255,000 +150.00% | 102,000 -96.71% | |
Cash from Investing Activities | -113.5M -382.46% | 40.2M +158.10% | -69.1M -176.28% | 90.6M +241.84% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 174.7M +493.12% | 29.4M +113.12% | 13.8M +2,150.49% | 614,000 -98.84% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | -16.76% -89.48% | -159.26% -82.35% | -902.50% -40.03% | -1,504.86% -29.07% | |
Return on Assets | -3.25% -89.65% | -31.39% -38.83% | -51.32% -19.28% | -63.58% +16.11% | |
Return on Equity | -5.10% -95.27% | -107.92% +9.07% | -98.95% +33.71% | -74.00% +16.69% | |
Revenue Growth | 153.52% -48.51% | 298.16% +1,951.35% | 14.53% N/A | 0.00% +100.00% | |
Current Ratio | 5.22 +115.97% | 2.42 -29.16% | 3.41 -42.68% | 5.95 -37.98% | |
Cash Ratio | 1.20 +49.38% | 0.80 +58.58% | 0.51 -84.28% | 3.22 +13.31% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow